Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Mylan Indian unit gets USFDA warning over quality control issue

Ruchika Sharma3 Sept 2020 12:42 PM IST

US: Mylan NV received a warning from U.S. regulators for failing to ensure key drug ingredients made at one of its plants in India were not...

Lupin launches rheumatoid arthritis drug Leflunomide in US

Ruchika Sharma3 Sept 2020 11:58 AM IST

Mumbai, Baltimore: Drugmaker Lupin Limited has announced the launch of Leflunomide Tablets USP, 10 mg and 20 mg, having received an approval from the...

Bristol Myers Squibb Onureg gets USFDA nod to treat Acute Myeloid Leukemia

Ruchika Sharma3 Sept 2020 9:45 AM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved Onureg® (azacitidine 300 mg...

Sanofi COVID-19 drug Kevzara fails test, clinical trails halted

Ruchika Sharma2 Sept 2020 5:12 PM IST

Paris: In a major setback, French drugmaker Sanofi, recently announced that the company has halted the clinical trials of its COVID-19 drug Kevzara...

Indian facilities of Quest Diagnostics acquired by Oncquest Labs

Ruchika Sharma2 Sept 2020 2:01 PM IST

New Delhi: Diagnostics chain Oncquest Laboratories on Monday said it has acquired Indian facilities of Quest Diagnostics, from clinical research...

Zydus Cadila muscle relaxant injection Cisatracurium Besylate gets USFDA okay

Ruchika Sharma2 Sept 2020 1:56 PM IST

Ahmedabad: Zydus Cadila has received final approval from the USFDA to market Cisatracurium Besylate Injection USP (US RLD: Nimbex ®) in the strength...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Morepen Labs net profit leaps over two-fold to Rs 19.36 crore in Q1

Ruchika Sharma2 Sept 2020 1:17 PM IST

API sales revenue during the quarter grew by 44 percent to Rs 162.06 crore, the filing said.

Religare Enterprises seeks funding from Burman family

Religare Health Insurance renames itself as Care Health Insurance, changes its logo

Ruchika Sharma2 Sept 2020 12:54 PM IST

The Company has changed its logo with a tagline " Health ki Guarantee".

Medical equipment supply to be terminated from October: Centre to Maha Govt

Ruchika Sharma31 Aug 2020 11:09 AM IST

The medical equipment which the Union government provided included PPE Kits,RT-PCR Kits, ventilators, N-95 masks, HCQ and other medicines and oxygen...

Alembic Pharma gets USFDA nod to diabetes drugs Empagliflozin, Linagliptin

Ruchika Sharma30 Aug 2020 2:39 PM IST

Vadodara: Alembic Pharmaceuticals Limited has recently announced that it has received tentative approval from the US Food & Drug Administration...

Intas Pharma COVID-19 specific Hyperimmune Globulin gets DCGI nod to conduct clinical trial

Ruchika Sharma30 Aug 2020 10:30 AM IST

Intas is among the world's first to adopt this approach for treating COVID-19 patients. This will be a Corporate Social Responsibility (CSR)...

Dr Reddys Labs: USFDA closes warning letter for three sites

Ruchika Sharma30 Aug 2020 10:15 AM IST

In November 2015, Dr Reddy's had said it had received a warning letter from the US Food and Drug Administration (USFDA) for three of its sites --...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok